<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
ARTERIAL VASCULAR ENGINEERING, INC.
--------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-27802 94-3144218
-------------------- -------------- ---------------------
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification Number)
3576 Unocal Place, Santa Rosa, California 95403
-------------------------------------------------
(Address of principal executive offices)
(707) 525-0111
------------------
(Registrant's telephone number, including area code)
Common Stock par value $0.001 per share ("Common")
(Title of each class of securities covered by this form)
N/A
---------------------------------------------------------
(Titles of all other classes of securities
for which a duty to file reports under Section 3(a) or 159(d) remains)
Place an X in the box(es) to designate the appropriate rule provision(s) relied
upon to terminate
Or suspend the duty to file reports:
[X ] Rule 12g-4(a)(1)(i) [ ] Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(i)
[ ] Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(i) [ ] Rule 12h-3(b)(2)(ii)
[ ] Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(1)(ii) [ ] Rule 15d-6
Approximate number of holders of record as of the certification or
notice date: ONE
Pursuant to the requirements of the Securities Exchange Act of 1934,
Arterial Vascular Engineering, Inc. has duly caused this Certification/Notice to
be signed on its behalf by the undersigned duly authorized person.
ARTERIAL VASCULAR ENGINEERING, INC.
By: /s/ Scott J. Solano
--------------------------------------
January 28, 1999 Scott J. Solano
President and Chief Executive Officer